Matthew R. Henn - Chief Scientific Officer and EVP at Seres Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer and EVP
Issuer Symbol
MCRB on Nasdaq
All Insider Reports
All Insider Reports

Matthew R. Henn - trading volume in the past year for Seres Therapeutics, Inc.

Holdings reported by Matthew R. Henn for Seres Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 7,677 $65,024 $8.47 15 Feb 2026 Direct
Restricted Stock Units 780 $18,996 $0.8105 15 Feb 2026 Direct Common Stock

Transactions reported by Matthew R. Henn for Seres Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.